Home Nanospectra Biosciences

Nanospectra Biosciences

AuroLase ® Pivotal Study Update: Four Clinical Trial Sites Added Notes Nanospectra Biosciences

The AuroLase pivotal study follows the successful first-in-human pilot study that enrolled 46 subjects at three U.S. sites. Pandemic related delays to the one-year end of study biopsies for the final subset of feasibility study subjects should be resolved within the next several weeks and, consequently, final results of the feasibility study are expected later this year.